Madrigal Pharmaceuticals, Inc. (BIT:1MDGL)

Italy flag Italy · Delayed Price · Currency is EUR
379.40
+6.80 (1.83%)
At close: Oct 31, 2025
1.83%
Market Cap8.10B
Revenue (ttm)438.99M
Net Income (ttm)-240.04M
Shares Outn/a
EPS (ttm)-10.91
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10
Average Volume4
Open411.40
Previous Close372.60
Day's Range372.60 - 411.40
52-Week Range237.50 - 411.40
Betan/a
RSI55.55
Earnings DateNov 4, 2025

About Madrigal Pharmaceuticals

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania. [Read more]

Industry Pharmaceutical Preparations
CEO William Sibold
Employees 528
Stock Exchange Borsa Italiana
Ticker Symbol 1MDGL
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.